As Fifth Third Bancorp (FITB) Stock Value Rose, Eaton Vance Management Boosted Its Stake by $503,220; Stadion Money Management Has Lifted Its Pfizer (PFE) Stake by $1.29 Million

May 16, 2018 - By Nellie Frank

Fifth Third Bancorp (NASDAQ:FITB) Logo

Eaton Vance Management increased its stake in Fifth Third Bancorp (FITB) by 1.08% based on its latest 2017Q4 regulatory filing with the SEC. Eaton Vance Management bought 16,774 shares as the company’s stock rose 1.62% while stock markets declined. The institutional investor held 1.58 million shares of the major banks company at the end of 2017Q4, valued at $47.82M, up from 1.56 million at the end of the previous reported quarter. Eaton Vance Management who had been investing in Fifth Third Bancorp for a number of months, seems to be bullish on the $23.55B market cap company. The stock increased 0.12% or $0.04 during the last trading session, reaching $34.35. About 4.21 million shares traded. Fifth Third Bancorp (NASDAQ:FITB) has risen 26.73% since May 16, 2017 and is uptrending. It has outperformed by 15.18% the S&P500.

Stadion Money Management Llc increased its stake in Pfizer Inc (PFE) by 239.04% based on its latest 2017Q4 regulatory filing with the SEC. Stadion Money Management Llc bought 35,804 shares as the company’s stock declined 3.13% with the market. The institutional investor held 50,782 shares of the health care company at the end of 2017Q4, valued at $1.84 million, up from 14,978 at the end of the previous reported quarter. Stadion Money Management Llc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $208.71B market cap company. The stock decreased 0.03% or $0.01 during the last trading session, reaching $35.68. About 13.34 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since May 16, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Investors sentiment increased to 1.06 in 2017 Q4. Its up 0.10, from 0.96 in 2017Q3. It is positive, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Howland Capital Mngmt Limited Liability Corp holds 0.23% or 79,989 shares. Bonness Enterprises reported 1.93% stake. Parkside Bancorporation And Tru holds 0.53% in Pfizer Inc. (NYSE:PFE) or 39,994 shares. Uss Invest invested in 185,300 shares or 0.08% of the stock. Pennsylvania-based Armstrong Henry H has invested 0.06% in Pfizer Inc. (NYSE:PFE). First Pacific Advsrs Ltd Liability Company invested in 0% or 13,000 shares. Cambridge stated it has 113,758 shares. Cutter & Brokerage holds 0.56% of its portfolio in Pfizer Inc. (NYSE:PFE) for 37,754 shares. Capital Fund Mgmt, a France-based fund reported 444,322 shares. Shoker Investment Counsel invested 1.01% of its portfolio in Pfizer Inc. (NYSE:PFE). Colrain Cap Ltd Liability Company has 114,797 shares. Meridian Mngmt Co has invested 0.61% of its portfolio in Pfizer Inc. (NYSE:PFE). Chesapeake Asset Management Limited Com holds 0.34% of its portfolio in Pfizer Inc. (NYSE:PFE) for 9,860 shares. Nikko Asset Mngmt Americas Inc has 335,841 shares. Stifel Fincl reported 0.79% of its portfolio in Pfizer Inc. (NYSE:PFE).

Since December 15, 2017, it had 0 insider buys, and 13 selling transactions for $17.75 million activity. On Monday, February 26 CORNWELL W DON sold $64,679 worth of Pfizer Inc. (NYSE:PFE) or 1,758 shares. SUSMAN SALLY had sold 33,368 shares worth $1.24 million on Monday, February 26. JOHNSON RADY A also sold $998,666 worth of Pfizer Inc. (NYSE:PFE) shares. Dolsten Mikael sold $501,398 worth of stock. $249,750 worth of Pfizer Inc. (NYSE:PFE) was sold by MACKENZIE ALEXANDER R. $1.52 million worth of Pfizer Inc. (NYSE:PFE) shares were sold by HILL CHARLES H.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer Is A Definite Buy For 2018” on April 30, 2018, also Streetinsider.com with their article: “Pfizer (PFE) Announces FDA Approval for Biosimilar RETACRIT” published on May 15, 2018, Seekingalpha.com published: “Pfizer: Buy This Dip?” on May 03, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Fool.com and their article: “Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK)” published on May 13, 2018 as well as 247Wallst.com‘s news article titled: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” with publication date: April 30, 2018.

Stadion Money Management Llc, which manages about $6.01 billion and $3.10B US Long portfolio, decreased its stake in Ishares Tr (IVV) by 142,267 shares to 1.40 million shares, valued at $377.08 million in 2017Q4, according to the filing. It also reduced its holding in Grainger W W Inc (NYSE:GWW) by 1,519 shares in the quarter, leaving it with 6,524 shares, and cut its stake in Spdr Ser Tr.

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer had 79 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Sunday, January 28 by SunTrust. Jefferies maintained the shares of PFE in report on Monday, October 16 with “Hold” rating. The stock has “Neutral” rating by Guggenheim on Friday, December 2. Piper Jaffray maintained the stock with “Overweight” rating in Friday, August 28 report. The company was downgraded on Wednesday, November 2 by BMO Capital Markets. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) on Tuesday, October 31 with “Buy” rating. JP Morgan reinitiated Pfizer Inc. (NYSE:PFE) rating on Thursday, April 7. JP Morgan has “Overweight” rating and $38 target. Cowen & Co upgraded Pfizer Inc. (NYSE:PFE) on Tuesday, October 20 to “Outperform” rating. The rating was maintained by Jefferies on Thursday, April 7 with “Buy”. Jefferies maintained the shares of PFE in report on Wednesday, August 16 with “Hold” rating.

Among 33 analysts covering Fifth Third (NASDAQ:FITB), 6 have Buy rating, 3 Sell and 24 Hold. Therefore 18% are positive. Fifth Third had 110 analyst reports since July 22, 2015 according to SRatingsIntel. The company was maintained on Tuesday, April 24 by Susquehanna. On Tuesday, June 7 the stock rating was downgraded by Susquehanna to “Neutral”. Compass Point upgraded Fifth Third Bancorp (NASDAQ:FITB) on Wednesday, March 29 to “Buy” rating. Hilliard Lyons upgraded the shares of FITB in report on Wednesday, January 25 to “Neutral” rating. Keefe Bruyette & Woods maintained Fifth Third Bancorp (NASDAQ:FITB) rating on Tuesday, December 12. Keefe Bruyette & Woods has “Hold” rating and $31.0 target. The company was maintained on Wednesday, January 25 by Wedbush. Jefferies maintained Fifth Third Bancorp (NASDAQ:FITB) on Tuesday, January 23 with “Hold” rating. The firm has “Neutral” rating given on Tuesday, November 24 by Piper Jaffray. The firm earned “Sell” rating on Thursday, December 7 by Robert W. Baird. The stock of Fifth Third Bancorp (NASDAQ:FITB) has “Hold” rating given on Thursday, June 8 by Jefferies.

More news for Fifth Third Bancorp (NASDAQ:FITB) were recently published by: Seekingalpha.com, which released: “Regional banks mull threat from Amazon” on April 26, 2018. Nasdaq.com‘s article titled: “New Research Coverage Highlights Graphic Packaging Holding, Regions Financial, Devon Energy, Fifth Third, Gastar …” and published on May 10, 2018 is yet another important article.

Since February 5, 2018, it had 0 insider purchases, and 11 insider sales for $6.84 million activity. Another trade for 568 shares valued at $19,218 was made by McWilliams Jelena on Friday, March 16. 35,000 shares were sold by Leonard James C., worth $1.18M. 7,500 shares were sold by Hazel Mark D, worth $246,098. BRUMBACK EMERSON L had sold 3,000 shares worth $100,316 on Monday, March 5. $2.84M worth of Fifth Third Bancorp (NASDAQ:FITB) shares were sold by CARMICHAEL GREG D. Shares for $119,895 were sold by Hoover Jewell D on Monday, February 12.

Fifth Third Bancorp (NASDAQ:FITB) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>